Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze URGN stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate URGN investment potential.

What is URGN stock price today?

Get real-time URGN stock price, historical data, and price charts on Financhill. Track URGN performance with our advanced analysis tools.

Is URGN a good investment?

Evaluate URGN investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy URGN stock?

To buy URGN stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of URGN?

View detailed market capitalization data and company valuation metrics for URGN on our comprehensive analysis page.

What is the P/E ratio of URGN?

Use our fundamental analysis tools to view URGN P/E ratio and compare valuation metrics with industry peers.

What are URGN earnings?

View URGN earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

UroGen Pharma Ltd. Stock Predictions

Share Price Moved. Momentum Hasn't Slowed.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

URGN
UroGen Pharma Ltd.

Last Price:

$23.46

Seasonality Move:

-2.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Valuation Up 5,000%. Shares Now $0.85 - Still Early?

UroGen Pharma Ltd. Stock Forecast

Over the next 52 weeks, UroGen Pharma Ltd. has on average historically risen by 9.4% based on the past 8 years of stock performance.
UroGen Pharma Ltd. has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
Is UroGen Pharma Ltd. Stock Undervalued?

The current UroGen Pharma Ltd. [URGN] share price is $22.85. The Score for URGN is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
URGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will UroGen Pharma Ltd. Stock Go Up Next Year?

Over the next 52 weeks, UroGen Pharma Ltd. has on average historically risen by 9.4% based on the past 8 years of stock performance.

UroGen Pharma Ltd. Stock Rating

Sell

UroGen Pharma Ltd. (URGN) is a Sell

Is UroGen Pharma Ltd. overpriced?

UroGen Pharma Ltd. has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%

UroGen Pharma Ltd. Stock Price History

Is URGN stock going to rise?

The current trend is relatively stagnant and URGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

urogen.com

52-Week Data

52-Week High:

30.00

52-Week Low:

3.42

Prediction Charts

Market Cap:

1.1B

Price in USD:

22.85

Volume:

1.5M

Beta:

1.30

Technical Analysis

SMA50:

21.63

SMA100:

20.31

SMA200:

15.54

52-Wk Change:

101.32%

Stock Predictions

Is UroGen Pharma Ltd. stock public?

Yes, UroGen Pharma Ltd. is a publicly traded company.
What is the UroGen Pharma Ltd. stock quote today?

The UroGen Pharma Ltd. stock price is 22.85 USD today.
How to buy UroGen Pharma Ltd. stock online?

You can buy UroGen Pharma Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-25	26.94	27.69	27.98	26.70
Nov-26	27.70	29.42	30.00	27.17
Nov-28	29.27	28.81	29.46	28.42
Dec-1	28.13	28.46	28.87	27.39
Dec-2	28.45	24.38	28.69	24.00
Dec-3	24.50	24.35	25.83	24.27
Dec-4	24.42	24.28	24.92	23.92
Dec-5	23.77	22.98	24.65	22.51
Dec-8	23.37	23.08	23.74	22.82
Dec-9	23.15	22.70	23.56	22.67
Dec-10	22.74	22.19	23.24	22.11
Dec-11	22.35	22.36	22.62	21.74
Dec-12	22.38	21.80	22.66	21.78
Dec-15	21.90	22.85	22.92	21.40

UroGen Pharma Ltd. Earnings

UroGen Pharma Ltd. Earnings Report: Per Share UroGen Pharma Ltd. Earnings Q1 Q2 Q3 and Q4 last year and next year.

UroGen Pharma Ltd. Forecast Revenue Growth

UroGen Pharma Ltd. Stock Analysis: Historical quarterly revenues per share for UroGen Pharma Ltd. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.49 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.00 per share, and an increase next year of $2.53 per share.

* UroGen Pharma Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.